Pandox Future Growth

OM:PNDX B - Analysts future estimates and past financials data (SEK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	7,412	1,543	743	1,950	1
12/31/2025	7,142	1,571	706	1,898	1
12/31/2024	6,962	1,647	1,125	1,589	1
3/31/2024	6,997	78	1,596	1,643	N/A
12/31/2023	6,849	-585	2,146	2,193	N/A
9/30/2023	6,774	648	2,190	2,222	N/A
6/30/2023	6,306	1,875	2,603	2,635	N/A
3/31/2023	6,014	2,959	2,579	2,611	N/A
12/31/2022	5,537	4,217	2,345	2,377	N/A
9/30/2022	4,740	4,355	2,037	2,134	N/A
6/30/2022	4,069	2,988	1,308	1,405	N/A
3/31/2022	3,389	1,611	827	924	N/A
12/31/2021	3,247	610	333	430	N/A
9/30/2021	2,968	51	394	461	N/A
6/30/2021	2,850	-368	350	417	N/A
3/31/2021	2,821	-691	83	150	N/A
12/31/2020	3,178	-1,399	393	460	N/A
9/30/2020	3,946	198	368	478	N/A
6/30/2020	4,598	543	841	951	N/A
3/31/2020	5,453	1,632	1,313	1,423	N/A
12/31/2019	5,553	2,706	1,824	1,934	N/A
9/30/2019	5,473	2,185	2,283	2,348	N/A
6/30/2019	5,363	2,776	1,823	1,888	N/A
3/31/2019	5,263	2,777	2,010	2,075	N/A
12/31/2018	5,124	2,820	1,645	1,710	N/A
9/30/2018	4,848	3,232	1,557	1,685	N/A
6/30/2018	4,559	2,945	1,749	1,877	N/A
3/31/2018	4,326	3,068	1,550	1,678	N/A
12/31/2017	4,269	3,140	N/A	1,693	N/A
9/30/2017	4,247	2,719	N/A	1,306	N/A
6/30/2017	4,235	2,761	N/A	1,286	N/A
3/31/2017	4,112	2,349	N/A	1,242	N/A
12/31/2016	3,945	2,201	N/A	1,195	N/A
9/30/2016	3,769	2,115	N/A	1,155	N/A
6/30/2016	3,661	1,951	N/A	1,237	N/A
3/31/2016	3,658	2,131	N/A	1,056	N/A
12/31/2015	3,529	2,131	N/A	864	N/A
9/30/2015	3,432	1,575	N/A	1,057	N/A
6/30/2015	3,281	1,390	N/A	830	N/A
3/31/2015	3,112	1,276	N/A	830	N/A
12/31/2014	3,076	1,253	N/A	881	N/A
12/31/2013	2,897	948	N/A	540	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PNDX B's forecast earnings growth (46.3% per year) is above the savings rate (0.9%).

Earnings vs Market: PNDX B's earnings (46.3% per year) are forecast to grow faster than the Swedish market (13.1% per year).

High Growth Earnings: PNDX B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PNDX B's revenue (2.2% per year) is forecast to grow faster than the Swedish market (1.5% per year).

High Growth Revenue: PNDX B's revenue (2.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PNDX B's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Pandox Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Consensus EPS estimates fall by 13%

Consensus EPS estimates fall by 31%

Price target decreased by 13% to kr143

Consensus EPS estimates fall by 12%

Consensus EPS estimates increase by 44%

Consensus forecasts updated

Recent updates

First quarter 2024 earnings released

An unknown buyer completed the acquisition of DoubleTree by Hilton Montreal from Pandox AB (publ) (OM:PNDX B).

Pandox AB (Publ) Approves Dividend

Upcoming dividend of kr4.00 per share

Pandox's (STO:PNDX B) Dividend Will Be Increased To SEK4.00

Full year 2023 earnings: EPS misses analyst expectations

Dividend increased to kr4.00

Pandox AB (publ) to Report Fiscal Year 2023 Results on Mar 08, 2024

Pandox AB (publ) Proposes a Dividend

Full year 2023 earnings: EPS misses analyst expectations

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2024 Results on Feb 06, 2025

Third quarter 2023 earnings released: EPS: kr2.48 (vs kr9.16 in 3Q 2022)

Pandox (STO:PNDX B) Takes On Some Risk With Its Use Of Debt

Pandox AB (publ), Annual General Meeting, Apr 10, 2024

Consensus EPS estimates fall by 13%

New minor risk - Profit margin trend

Second quarter 2023 earnings: Revenues exceed analyst expectations

Consensus EPS estimates fall by 31%

Does Pandox (STO:PNDX B) Have A Healthy Balance Sheet?

Price target decreased by 13% to kr143

Insider recently bought kr895k worth of stock

First quarter 2023 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Upcoming dividend of kr2.50 per share at 2.0% yield

Key Executive recently bought kr536k worth of stock

With EPS Growth And More, Pandox (STO:PNDX B) Makes An Interesting Case

Insider recently bought kr429k worth of stock

Chief Commercial Officer recently bought kr282k worth of stock

Chief Executive Officer recently bought kr490k worth of stock

Consensus EPS estimates fall by 12%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Pandox AB (publ) Proposes Dividend for 2022

An unknown buyer acquired InterContinental from Montreal Pandox AB (publ) (OM:PNDX B) for CAD 80 million.

Is Now An Opportune Moment To Examine Pandox AB (publ) (STO:PNDX B)?

Pandox AB (publ) to Report Fiscal Year 2022 Results on Mar 10, 2023

Second quarter 2022 earnings released: EPS: kr7.45 (vs kr0.038 loss in 2Q 2021)

Consensus EPS estimates increase by 44%

Industry Analysts Just Upgraded Their Pandox AB (publ) (STO:PNDX B) Revenue Forecasts By 16%

Pandox AB (publ) to Report Fiscal Year 2022 Results on Feb 10, 2023

Is Pandox (STO:PNDX B) Using Too Much Debt?

Pandox AB (publ) (OM:PNDX B) acquired Hotel in the UK from Starwood Capital Operations, LLC for £40 million.

Pandox AB (publ) Announces Nomination Committee for the AGM 2023

Pandox AB (publ) (OM:PNDX B) agreed to acquire NH Brussels Louise in central Brussels from NH Hotel Group, S.A. (BME:NHH).

Consensus forecasts updated

Investor sentiment improved over the past week

Price target increased to kr168

Second quarter 2022 earnings: Revenues exceed analyst expectations

Pandox AB (publ), Annual General Meeting, Apr 12, 2023

Pandox AB (Publ) Announces Executive Changes

We Think Pandox (STO:PNDX B) Is Taking Some Risk With Its Debt

Pandox AB (publ) to Report Fiscal Year 2023 Results on Feb 08, 2024

Director recently bought kr401k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Consensus EPS estimates fall by 28%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Pandox AB (publ) to Report Fiscal Year 2021 Results on Mar 11, 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Analysts Just Made A Stunning Upgrade To Their Pandox AB (publ) (STO:PNDX B) Forecasts

Consensus revenue estimates increase by 37%

Consensus EPS estimates fall by 20%

Pandox (STO:PNDX B) Has A Somewhat Strained Balance Sheet

Third quarter 2021 earnings released

Price target increased to kr158

Pandox (STO:PNDX B) Use Of Debt Could Be Considered Risky

Price target increased to kr153

Second quarter 2021 earnings released: kr0.04 loss per share (vs kr1.79 loss in 2Q 2020)

Pandox (STO:PNDX B) May Have Issues Allocating Its Capital

Pandox (STO:PNDX B) Seems To Be Using A Lot Of Debt